Skip to main content
AI/ML Innovations Inc. logo

AI/ML Innovations Inc. — Investor Relations & Filings

Ticker · AIML ISIN · CA00143Y1034 LEI · 5493004TJHMBXORVTD12 CSE Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 532 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country CA Canada
Listing CSE AIML

About AI/ML Innovations Inc.

https://aiml-innovations.com/

AI/ML Innovations Inc. is a digital healthcare technology company specializing in the application of Artificial Intelligence (AI) and Machine Learning (ML) neural networks to revolutionize non-invasive medicine and biometric intelligence. The company develops proprietary platforms that leverage advanced signal processing and deep learning to convert complex biometric data into actionable clinical insights, supporting proactive and personalized care. Its flagship technology, MaxYield, is a cutting-edge Signal Processing Neural Network designed to extract high-fidelity signals from noisy recordings, initially focused on enhancing the clarity and accuracy of ECG data by delivering clean, "Neuralized" waveforms and precise PQRST data walls. Through its subsidiaries, the company provides AI-powered solutions like CardioYield™ for Holter analysis, aiming to integrate seamlessly with existing clinical and wellness workflows.

Recent filings

Filing Released Lang Actions
Report of exempt distribution (45-106F1) (amended).pdf
Regulatory Filings Classification · 95% confidence The document is Form 45-106F1 (“Report of Exempt Distribution”) filed under Canadian National Instrument 45-106. It is a statutory compliance form detailing securities distribution particulars, not an earnings release, board change, or full financial report. It fits the catch-all “Regulatory Filings” category.
2026-05-22 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 88% confidence The document is a completed Canadian securities regulatory form (Form 45-106F1) detailing an exempt distribution under National Instrument 45-106. It provides issuer details, distribution dates, purchaser breakdowns and compliance information. This is neither an earnings release, financial report, nor a management presentation, but a regulatory compliance filing. It falls under the general regulatory filings category.
2026-05-21 English
Material change report - English.pdf
Capital/Financing Update Classification · 90% confidence The document is a Form 51-102F3 Material Change Report filed under Canadian NI 51-102, announcing and describing in detail the closing of the second tranche of a private placement financing via convertible debentures to raise C$1.9175 million (capital structure change/fundraising). This is not an Annual Report, earnings release, legal filing, or mere report release notice, but a direct update on a financing transaction. It thus falls under Capital/Financing Update (CAP).
2026-05-15 English
News release - English.pdf
Regulatory Filings
2026-05-13 English
News release - English.pdf
Regulatory Filings
2026-05-12 English
News release - English.pdf
Regulatory Filings
2026-05-11 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.